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Monoclonal antibody (MAb) preparations specific for the enteric adenoviruses of subgenus F (AdF) were
generated and evaluated as typing reagents in virus neutralization tests and enzyme-linked immunosorbent
assays (ELISAs). A panel of 11 genome types of adenovirus 40 (Ad40), 24 genome types of Ad4l, and 47
adenovirus prototype strains was used to determine the specificities of the MAbs in the two assays. In this way
two MAbs, MAb 40-1 (anti-Ad40) and MAb 41-1 (anti-Ad4l) were selected. These two MAbs showed strict type
specificity in both assays. A third MAb reacted in an ELISA with all 47 human adenovirus types. With two
other MAbs, three antigenic subtypes ofAd41 could be distinguished by their reactivities in virus neutralization
tests and ELISAs. On the basis of the five selected MAbs, a sensitive ELISA system was developed for the direct
detection and simultaneous typing and subtyping ofAd4O and Ad4l present in stool specimens. The five MAbs
were also used to study the epidemiology of infections with Ad40 and Ad4l in The Netherlands in the period
1981 through 1989. It was shown that there were no significant fluctuations in the annual incidence of the
cluster of enteric adenoviruses as a whole. This cluster should therefore be considered to belong to the
"endemic" rather than the "epidemic" adenoviruses. The relative incidence ofAd4O infections compared with
that of Ad4l infections changed considerably during the period studied; the proportion ofAd41 infections rose
from about 30%o in 1981 to about 95% in 1986, after which it stabilized at 90 to 95%. The proportion of one
of the subtypes of Ad41 (Ad41 subtype M3) increased from about 40 to 80% in the same period.
Among the 47 types and candidate types of human ade-
noviruses recognized at present (16), the "enteric" or "fas-
tidious" adenoviruses 40 and 41 (Ad4O and Ad4l, respec-
tively) constitute subgenus F (AdF) (9, 29, 33). It is more
difficult to isolate and type members of this subgenus than
the other human adenoviruses (3, 9, 11, 19), and only after
the advent of monoclonal antibody (MAb)-based enzyme-
linked immunosorbent assays (ELISAs) (14, 15, 26, 27),
epidemiological reports on these highly prevalent human
pathogens are becoming more frequent (2, 4, 6, 7, 13, 20, 21,
23, 25, 30, 31, 34). Extensive controlled studies by Brandt et
al. (3) showed that the presence of AdF, in contrast to the
presence of other adenoviruses (Ad non-F), in the stools of
infants was associated with the occurrence of diarrhea.
Although Ad4O and Ad4l exhibit extensive cross-reactiv-
ity in virus neutralization (VN) assays and cannot be distin-
guished in hemagglutination inhibition assays with animal
antisera (9), they are defined as separate types on the basis of
major differences in DNA restriction enzyme (DRE) patterns
(9, 29, 33). Since the definition of adenovirus types is
primarily based on the antigenic differences found in VN
tests (37), we developed, in line with earlier studies (14, 15,
26, 27), neutralizing MAbs for the typing of AdF in VN
assays.
In the present study, we evaluated the specificities of the
MAbs that we developed with a panel of Ad4O and Ad4l
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genome types. Part of this evaluation has been documented
previously (32). The MAbs were subsequently used for the
construction of an ELISA system for the direct detection
and typing of AdF in stool specimens and for studies on the
epidemiology of infections with Ad4O and Ad4l and its
subtypes in The Netherlands from 1981 to 1989.
MATERLALS AND METHODS
Viruses, fecal specimens, and diagnostic procedures. Proto-
type strains of human Adl to Ad36 and Ad39 were obtained
from the American Type Culture Collection (ATCC), Rock-
ville, Md. Prototype strains Ad37, Ad38, Ad4O, and Ad4l
were isolated at the Rijksinstituut voor Volksgezondheid en
Milieuhygiene (RIVM) (8-10). Prototype strains Ad42 to
Ad47 were received from R. Wigand, Homburg, Germany.
For the determination of the specificities of the various
MAbs within subgenus AdF, the panels of 11 genome types
of Ad4O and 24 genome types of Ad4l described earlier (32)
were used.
For other specificity studies, the following animal adeno-
viruses were used. Eighteen simian adenovirus prototype
strains, canine adenovirus type 1, and mouse adenovirus FL
were obtained from ATCC. The simian adenovirus (SA)
prototypes included SA17, simian virus prototype 1 (SV1),
SV11, SV15, SV17, SV20, SV23, SV25, SV27, SV30, SV31,
SV32, SV33, SV34, SV36, SV38, SV39, and V340 (ATCC
VR-541). Canine adenovirus type 2 was the vaccine strain
Toronto A26/61. The strains were propagated at RIVM in
cell cultures originating from the corresponding animal spe-
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cies. The guinea pig adenovirus preparation was a sucrose
gradient-purified suspension of lung tissue from infected
animals.
Between 1981 and 1989, 6,666 fecal specimens from pa-
tients with gastroenteritis (mainly children) were sent by
physicians to RIVM for diagnostic examination. Fecal spec-
imens found to contain adenoviruses were used in the
present study as 10% (vol/vol) fecal suspensions in phos-
phate-buffered saline (pH 7.2). The patients lived in various
parts of The Netherlands, and multiple samples coming from
the same household were excluded from the study. Diagnos-
tic procedures carried out with these samples included
conventional virus isolation in human embryonic fibroblasts
and HEp-2 cell cultures and screening by an adenovirus
genus-specific immunofluorescence test with fluorescein
isothiocyanate-labeled gamma globulin from horse anti-AdlO
antiserum, after short-term cultivation of the sample in
LLC-MK2D cells for 48 h (SCIF-adeno) (9). The same
specimens were also tested for rotavirus by a similar locally
developed test (SCIF-rota). After 1987, the SCIF tests were
replaced by the ELISAs described below. In total, 265
(4.0%) of the 6,666 fecal specimens were found to be positive
for adenovirus in SCIF or ELISA and negative for adenovi-
rus in the conventional virus isolation procedures. By inoc-
ulation of Graham 293 cell monolayers, AdF was isolated
from all 265 specimens and was subsequently typed in VN
assays. During the period 1981 to 1989, 1,453 (21.8%) of the
6,666 fecal samples scored positive in the SCIF-rota or the
ELISA for rotavirus detection.
Additional AdF strains were part of earlier studies. Seven
were from Glasgow, United Kingdom (19), four were from
Atlanta, Ga. (11), and seven were from Sandringham, Re-
public of South Africa (17, 18). Seven fecal samples from the
study of Scott-Taylor et al. (24) were kindly provided by
those authors. A collection of 57 fecal specimens were
selected by negative-contrast electron microscopy (EM),
immune EM (IEM), or DRE mapping in Manchester, United
Kingdom (39).
Virus isolation, VN tests, DRE analysis, and negative-
contrast EM techniques. Ad4O and Ad4l were cultivated in
Graham 293 or tertiary cynomolgus monkey kidney (tMK)
cells maintained in Eagle's minimal essential medium sup-
plemented with 0.5 ,ug of crystallized trypsin (Merck, Darm-
stadt, Federal Republic of Germany) per ml, as described
previously (9, 10). Preparation of animal antisera, VN tests,
and DRE analysis were also performed as described earlier
(9, 32). Strains of AdF were typed in VN tests either with
polyclonal animal antisera or with the type-specific MAbs
from the present study. The MAb-based VN assays were
performed without prior virus isolation. Three aliquots of a
10% fecal suspension were incubated with equal volumes of
a fixed dilution (usually 1:500) of MAb 40-1 (anti-Ad4O), a
fixed dilution (usually 1:100) of MAb 41-1 (anti-Ad4l), or
dilution buffer, respectively. After 30 min at room tempera-
ture, the mixtures were used to inoculate tMK cell mono-
layers in tubes which were subsequently incubated in roller
drums at 37°C. Usually, the type could be read after 2 or 3
days. EM and IEM techniques have been described previ-
ously (39).
Development of MAbs. (i) MAbs to Ad4O. Ad4O strain
Dugan (ATCC VR-931) was propagated in tMK cells. About
350 ml of the supernatant of an infected cell culture showing
complete cytopathic changes was concentrated 20-fold by
ultrafiltration, and the virus was purified in a CsCl gradient,
which yielded about 1012 physical virus particles (about 0.1
mg). This preparation was used for immunization of BALB/c
mice. The methods used for hyperimmunization of mice,
fusion of spleen cells with P3/X-63 Ag 8-653 myeloma cells,
and selective growth of hybridoma cells and production of
ascites have been described previously (22). Supematants of
hybridoma cell cultures were screened by VN tests with an
amount of Ad4O capable of producing a cytopathic effect in
25% of tMK cells after incubation at 37°C for 3 days. The
supernatants were also screened by ELISA (see below).
Selected hybridomas were cloned twice by the limiting
dilution method.
(ii) MAbs to Ad4l. Prototype Ad4l strain Tak (ATCC
VR-930) was propagated in HEp-2 cells and was concen-
trated, purified, and used for the generation of MAbs by the
procedure described above.
ELISA. The wells of high-binding-capacity microplates
(Nunc, Roskilde, Denmark) were coated with gamma glob-
ulin. The gamma globulin was obtained by caprylic acid
precipitation from horse antiserum to AdlO and was resolved
in a carbonate buffer (pH 9.6) to a concentration of 20 ,g/ml.
The coating was performed at pH 9.6 for 2 h at 37°C or
overnight at 4°C. The wells were washed with phosphate-
buffered saline (pH 7.2) containing 0.05% (vol/vol) Tween
20, 100 ,ul of a 1 or 10% (vol/vol) fecal suspension was added
to each well, and the plates were incubated at 37°C for 2 h.
The wells were washed again as described above and the
plates were incubated for 1 h at 37°C with 100 ,ul of dilutions
of MAbs specific either for adenovirus genus antigen, Ad4O,
or Ad4l, with each MAb being applied in a different well.
The MAbs were purified by sodium sulfate precipitation,
labeled with horseradish peroxidase (Nordic, Tilburg, The
Netherlands), and diluted in phosphate-buffered saline (pH
7.2) containing 0.5% (vol/vol) Tween 20 and 0.5% (wt/vol)
bovine serum albumin. For each conjugated MAb, the
dilution in use was attuned to the least reactive genome
types, e.g., Ad41/M3 subtype for MA41-1 (see Table 4). In
practice, 2 ,ug of MAb 40-1 per ml and 4 ,ug of MAb 41-1 per
ml was used. After washing, 3,3',5,5'-tetramethylbenzidine
(Sigma, St. Louis, Mo.) was added as a substrate. The
enzyme reaction was stopped with sulfuric acid after 10 min,
and the extinction coefficient measured at 450 nm.
Samples were considered positive when the extinction
coefficient was reproducibly 0.100 units greater than the
value of the control well without sample. This cutoff value is
based on the results obtained with a series of 144 fecal
specimens which did not test positive for adenovirus in virus
culture assays on Graham 293 cells. Their extinction coeffi-
cients did not exceed the control value by more than 0.040.
If the extinction coefficient found with MAb d-gl (antigenus)
was greater than 1.000 and those produced by the AdF-
specific MAbs were less than 0.100, the specimen was
considered to contain Ad non-F. ELISA titers were defined
as the reverse of the highest dilution of antigen- or antibody-
containing preparations which showed, after correction for
the control value, an extinction coefficient of greater than
0.100. In the present report, the term "typing-ELISA"
refers to the ELISAs with conjugated MAb 40-1, MAb 40-2,
and MAb d-gl described in this paragraph, whereas the term
"genus-specific ELISA" refers to the ELISA with MAb
d-gl only. All positive and borderline-negative samples were
repeat tested and checked by virus culture when the diag-
nosis of patients was involved. All viruses isolated were
typed by the VN test. The presence of Ad4O or Ad4l was
also confirmed in the ELISA in a blocking test. Equal
volumes of fecal specimen and polyclonal anti-Ad4O or
anti-Ad4l antiserum were incubated at 37°C for 1 h. Reduc-
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TABLE 1. Reactivities of MAbs in VN tests and the ELISA
Reactivities in VN tests Reactivities in ELISA
MAba Isotype Ad40 Ad4l Non-F Ad40 Ad4l Non-F
(n = lb) (n = 24b) (n = 45C) (n = llb) (n = 24b) (n = 45C)
MA40-1 IgA 11 -d - 11 -
MA40-2 IgGl 11 - NT 10 -
MA40-3 IgG2a - - NT 11
MA40-4 IgG2a - - NT 10 -
MA41-1 IgG2a - 24 - - 24
MA41-2 IgG3 - 12 NT - 12 -
MA41-3 IgG2b - 6 NT - 6 -
MAd-gl IgG2a - - - 11 24 45
MAd-g2 IgGl NT NT NT 11 24 45
MAd-g3 IgGl NT NT NT 11 24 31
MAd-g4 IgG2b NT NT NT - 18 9
a MAbs MA40-1 and MA41-1 have been used in earlier work (32, 36, 40, 41) under the designations 5-8 and 5-15, respectively, and MAbs MA41-2, and MA41-3
have been applied in a previous study (32) under the designations 1-23 and 7-14.
b Number of genome types (DNA variants).
c Number of serotypes.
d No reactivity with any of the genome types or serotypes: titer <10.
e Not tested.
tion of the extinction coefficient by 80% or more was
considered proof of the presence of the virus concerned.
MAb 40-1 and MAb 41-1 also formed the basis of an
experimental kit for commercial distribution (40). Because of
substantial differences in design, the performances of this
assay cannot be considered equal to those of the ELISA
described here. The commercial kit was not available to us
for comparison and has not yet been marketed.
For detection of rotavirus by ELISA, a sandwich-type
assay based on locally prepared polyclonal anti-SA-11 anti-
serum was used.
RESULTS
Generation of MAbs against AdF. Hybridomas producing
MAbs that were reactive with AdF were generated from
BALB/c mice immunized with Ad4O or Ad4l. Fifteen hybrid-
omas were selected on the basis of their specificity profiles in
VN tests or ELISAs with the aid of the panel of 11 genome
types of Ad4O, 24 genome types of Ad4l, and 45 Ad non-F
prototypes. The following specificities were found for these
MAbs (Table 1).
(i) MAbs specific for Ad4O. Four hybridomas obtained from
mice immunized with Ad4O produced MAbs (MAb 40-1 to
MAb 40-4) that recognized Ad4O but not any of the other
adenoviruses, including Ad4l. All MAbs reacted in the
ELISA (titers of ascitic fluids, 104 to 105), and two MAbs
(MAb 40-1 and MAb 40-3) also reacted in VN tests (titers of
ascitic fluids, 105 to 106) with all or most of the 11 genome
types of Ad4O but with none of the 24 genome types of Ad4l
or 45 Ad non-F prototypes (Tables 2 and 3).
(ii) MAbs specific for Ad4l. Three of the hybridomas
obtained from Ad4l-immunized mice were selected on the
basis of the reactivities of their MAbs (MAb 41-1, MAb 41-2,
and MAb 41-3) in both VN tests and ELISA, with all or part
of the 24 genome types of Ad4l but not with any of the other
adenoviruses, including Ad4O (Tables 2 and 4). Three anti-
genic subtypes of Ad4l (Ad41/M1, Ad41/M2, and Ad41/M3)
were distinguished among the 24 genome types on the basis
of the specificities of the three selected MAbs in VN tests
(Table 2). Ad41IM1 was recognized by all three MAbs,
Ad41/M2 was recognized by MAb 41-1 and MAb 41-2, and
Ad41/M3 was recognized only by MAb 41-1. The same
TABLE 2. Neutralization titers of MAbs (mouse ascitic fluids) and rabbit antiserum reactive with Ad4O and Ad4l
Median log10 neutralization titer' of MAb or RAb DNA sitec
Groups of genome types Subtype
MA40-1 MA40-2 MA41-1 MA41-2 MA41-3 RA6 E1 H3
Ad4O/D1-11 except D8 5.4-6.3 6.0-7.2 _d 1.4 - 2.4
Ad4O/D8 5.6 3.6 1.6
Ad41/D1,3,6,7,8,17 Ml 5.0-5.7 3.0-3.9 4.5-5.1 2.4-3.0 NS NS
Ad41/D2,5,9,10,14,21 M2 - 5.1-6.3 3.2-3.8 2.2-3.2 + NS
Ad4l/D4,11,12,15,16,18, M3 3.8-4.5 2.2-3.4 NS +
19,20,22,23,24
Ad41/D13 M3 5.7 3.2 NS +
Non-F prototypes Adl-47 e e
a Antibody preparations were titrated in twofold dilutions in duplicate tests against each of 11 genome types of Ad40 and each of 24 genome types of Ad4l.
Standard error of the mean, 0.15.
b RA, rabbit antiserum to Ad41/D1/Tak/Netherlands/73 (Ml).
c DNA restriction enzyme sites for EcoRI (E1) and HindIII (H3), respectively. NS, no site.d <10d, titer <1.0.
e MA40-1 and MA41-1 did not react to non-F prototypes Adl-47.
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TABLE 3. ELISA titers of MAbs (mouse ascitic fluids) reactive with Ad4O only or with both AdF and non-F adenoviruses
(indirect tests)
Median loglo ELISA titer of MAb'
Genome types
40-1 40-2 40-3 40-4 MAd-gl MAd-g2 MAd-g3 MAd-g4
Ad4O/D1-11 except D7,8 4-5 2-3 4-5 4-5 3-5 5-6 4-5 b
Ad4O/D7 2.5 1.5 1.5 0.5 3 3 4.5
Ad4O/D8 4 0.5 3.5 4 3.5 3.5 4.5
Ad4l 4-5 5-6 4-5 varc
Non-F prototypes Adl-47 - 3-5 5-6 2-5 var
a MAbs were titrated in 10-fold dilutions in duplicate tests against each of 11 genome types of Ad4O and each of 24 genome types of Ad4l. Standard error of
the mean, 0.5.b_, titer <10.
Various reactivities, see text.
specificities of these MAbs were found in the ELISA (Table
4).
From both theoretical and practical points of view, it is
interesting that quantitative differences in the reactivities of
some of the MAbs were observed with different subtypes of
Ad4l; the titers of MAb 41-1 against subtypes Ad41/M1 and
Ad41/M2 were 40- to 100-fold higher than the titers against
subtype Ad41/M3 in both VN tests and ELISA (Tables 2 and
4). Ad4l subtypes Ml, M2, and M3 could not be distin-
guished in VN assays with hyperimmune rabbit antiserum to
Ad41/D1 strain Tak (Table 2).
(iii) MAbs reactive with both AdF and Ad non-F. Four
hybridomas were obtained from Ad4l-immunized mice; the
hybridomas produced MAbs (MAb d-gl, MAb d-g2, MAb
d-g3, and MAb d-g4) that bound in the ELISA to all or part
of the AdF genome types but also to Ad non-F (Table 3).
MAb d-gl did not exhibit activity in the VN test. MAb d-gl
and MAb d-g2 reacted with all of the adenoviruses tested,
including the 11 genome types of Ad4O and the 24 genome
types of Ad4l. MAb d-g3 bound to all 35 genome types of
AdF and also to all Ad non-F prototypes, although up to
1,000-fold differences in titers were found with the various
Ad non-F types. MAb d-g4 reacted with adenovirus types 3,
7, 9, 11, 14, 15, 16, 21, 34, 35, 41, and 47. However, of Ad4l,
only subtypes Ad4l/M1 and Ad4l/M3 were recognized by
this MAb, which offered an extra opportunity to discriminate
between the three subtypes. As was also demonstrated for
the reactivities of MAb 41-1 to the Ad4l subtypes, some of
the genus-specific MAbs showed quantitative differences in
their reactivities with some of the genome types of Ad4O and
some of the Ad non-F prototypes (Table 3).
TABLE 4. ELISA titers of MAbs (mouse ascitic fluids)
reactive with Ad4l (indirect tests)
Median loglo ELISA titer
Genome types Subtype of MAbl
41-1 41-2 41-3 MAd-g4
Ad4O/D1-11 _bb _
Ad41/D1,3,6,7,8,17 Ml 4-5 3-4 3-4 4.0
Ad4l/D2,5,9,10,14,21 M2 4-5 3-4 -
Ad41/D4,11,12,13,15,16, M3 2-3 - - 4.0
18,19,20,22,23,24
Non-F prototypes Adl-47 - - - var'
a MAbs were titrated in 10-fold dilutions in duplicate tests against each of 11
genome types of Ad4O and each of 24 genome types of Ad4l. Standard error
of the mean, 0.5.
b
_, titer <10.
Various reactivities, see text.
MAb-based typing ELISA for Ad4O and Ad4l. MAbs 40-1,
41-1, and d-gl, which reacted with Ad4O, Ad4l, and all
human adenoviruses, respectively, were incorporated in an
ELISA system for the detection and typing ofAdF in clinical
specimens. The sensitivity of this typing ELISA system was
compared with those of virus detection by SCIF, EM, and
virus isolation procedures by using panels of clinical speci-
mens. The specificity of the ELISA was assessed by con-
ducting VN tests with adenovirus type-specific antisera and
by using reference preparations of other enteric viruses.
(ii) Comparison of the typing ELISA with virus isolation and
EM. Among 159 fecal specimens collected from the same
number of epidemiologically unrelated diarrheic children, 8
scored positive in both the typing ELISA and virus isolation
tests in Graham 293 cells (Table 5). Of these samples, six
contained AdF and two contained Ad non-F. In addition,
four specimens scored positive only in the virus isolation
assay. All four isolates from these specimens proved to be
Ad non-F, however. Among 853 fecal samples of similar
origin, 41 scored positive in the genus-specific ELISA. Virus
isolation showed that 10 of these samples and 20 ELISA-
negative specimens contained Ad non-F. Thus, as expected,
the sensitivity of the typing ELISA for the detection of Ad
non-F is lower than that of virus isolation.
All of the 44 fecal samples which scored positive for
adenovirus by EM and containing AdF, as confirmed by VN
assays, were also positive in the typing ELISA. Thirty-nine
of 43 fecal samples in which AdF was demonstrated by the
typing ELISA and virus isolation also scored positive by
EM.
By using another approach for assessing the sensitivity of
the ELISA, three pools of five fecal samples each were
prepared; these fecal samples contained the most prevalent
genome types of Ad4O and Ad4l in The Netherlands, i.e.,
Ad40/D1, Ad41/D2, and Ad4l/D12, respectively (32). Serial
threefold dilutions of these pools were tested in the typing
ELISA and by the EM and virus isolation procedures. For
TABLE 5. Comparison of the typing ELISA with virus isolation
tests with fecal specimens from diarrheic children
No. of specimens with the following re-
ELISA sult by virus isolation tests
result Total
(AdF) (Ad non-F)
+ 6 2 0 8
- 0 4 147 151
Total 6 6 147 159
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TABLE 6. Comparison of the typing ELISA with a genus-
specific immunofluorescence test (SCIF-adeno) with fecal
specimens from diarrheic children
No. of specimens with the following re-
ELISA sult by SCIF-adeno
result + Total
(AdF) (Ad non-F)
+ 18 4 0 22
- 1 5 472 478
Total 19 9 472 500
each pool, the ELISA was still positive at dilutions of
between 10O4 and 10-48 and EM was still positive at
dilutions of 10-, whereas virus was still isolated at dilutions
of up to 10-5.8 (Ad40/D1) and 10-7i3 (Ad4l/D2 and Ad41/
D12).
In order to determine the smallest quantity of viral antigen
that could be detected by the newly developed ELISA, Ad4O
strain Dugan and Ad4l strain Tak were purified in CsCl
gradients. Serial threefold dilutions of these purified virus
preparations were tested in the typing ELISA. MAb 40-1
proved to be able to detect 0.01 Vg of Ad4O, MAb 41-1
detected 0.05 ,ug of Ad4l, MAb 41-2 detected 0.09 ,ug of
Ad41, MAb 41-3 detected 0.05 ,ug of Ad4l, and MAb d-gl
detected 0.04 ,ug of Ad4O and 0.13 ,ug of Ad4l antigen per ml.
(ii) Comparison of the typing ELISA with SCIF-adeno.
Among 500 fecal samples from diarrheic children, 22 scored
positive in both assays (Table 6). Upon virus isolation, 18 of
these specimens yielded AdF and 4 yielded Ad non-F. No
sample was positive only in the typing ELISA. Six were
positive only in the SCIF, and only one of the corresponding
six isolates belonged to subgenus F. In order to compare the
sensitivities of the ELISA and the SCIF more accurately,
116 SCIF-positive stool samples containing Ad4O or Ad4l
were tested in the ELISA. A total of 113 of these specimens
were positive by the ELISA.
(iii) Specificity of the typing ELISA. Sixty fecal samples
from which Ad4M was isolated and 139 fecal samples from
which Ad4l was isolated were tested in the typing ELISA.
All scored positive. In 197 cases (99%), the typing results
agreed with the results of the VN assays. In two samples
which yielded only Ad4l by the virus isolation method, the
ELISA demonstrated the presence of both Ad4O and Ad4l.
Seven fecal samples originating from Canada that contained
Ad4l and that had escaped detection by a commercial
MAb-based ELISA (24) scored positive for Ad4l in the
typing ELISA.
All 18 simian adenovirus prototype strains tested proved
to react with MAb d-gl and MAb d-g2 in the genus-specific
ELISA. The same MAbs in the same assay, however,
produced negative results with adenoviruses from other
animals, including mice, guinea pigs, and dogs.
All 12 fecal samples shown to contain rotavirus, astrovi-
rus, calicivirus, or Norwalk virus (three samples for each
virus) by EM scored negative in the typing ELISA.
Epidemiological studies concerning Ad4O and Ad4l infec-
tions. (i) Age distributions of individuals with symptomatic
Ad4O and Ad4M infections. On the basis of the results of
diagnostic testing of 6,666 fecal specimens from diarrheic
patients in The Netherlands in the period 1981 to 1989, the
age distributions for diarrhea caused by Ad4M and Ad4l
proved to be similar to those for gastroenteritis caused by
rotavirus (Fig. 1). It is interesting that the adenovirus infec-
0- 3- 6- 9- 12- 15- 18- 21- 24- 36&>48
Age in months
FIG. 1. Age distributions of infections with Ad4O, Ad4l, and
rotavirus in the period 1981 through 1989. The curve marked "Ad4O
+ Ad41" represents the combined numbers of infections with Ad4O
and Ad4l. On the abscissa, 0 means 0 through 2 months of age, 3
means 3 through 5 months of age, and so on.
tions occurred most frequently in the first half year of life,
whereas the rotavirus-associated diarrhea was most preva-
lent in the second half of the first year of life.
(ii) Monthly distributions ofAd4O and Ad41 infections. Data
for the period 1981 through 1989 demonstrate that Ad40 and
Ad4l infections are not subject to major seasonal influences,
although they seemed to occur slightly more frequently in
winter and early autumn months (Fig. 2). For comparison,
the monthly incidences, over the same period, of infections
with the subgenus C viruses Adl and Ad2 and with the
subgenus B viruses Ad3 and Ad7 are presented in Fig. 3.
(iii) Annual distributions of Ad40 and Ad4l infections. The
incidence of AdF infections did not vary greatly from year to
year during the study period 1981 through 1989 (Fig. 4). The
distributions of infections with Adl, Ad7, and rotavirus,
diagnosed during the period 1961 through 1989, are shown
for reference purposes in Fig. 4.
(iv) Changing relative incidence of Ad4O infections com-
pared with that of Ad4l infections. Although the total yearly
number of AdF isolations did not show major variations
between 1981 and 1989, the ratio of the frequency of isola-
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FIG. 2. Monthly distributions of infections with Ad4O and Ad4l
in the period 1981 through 1989. The designation "Ad4O + Ad41" is
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FIG. 3. Monthly distributions of infections with nonenteric ade-
noviruses and rotavirus in the period 1981 through 1989. The
designations "Adl + Ad2" and "Ad3 + Ad7" have meanings
analogous to that for "Ad4O + Ad4l" described in the legend to
Fig. 1.
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FIG. 5. Proportions of Ad4l and Ad41/M3 infections in the
period 1981 through 1989. The percentages of the number of Ad4l
infections relative to the total number of AdF infections and the
percentages of the number of Ad41/M3 infections relative to the
total number of Ad4l infections per year are plotted.
DISCUSSION
from about 2:1 in 1981 to about 1:20 in 1986 and thereafter
(Fig. 5). The changing ratio between the frequencies of
isolation of Ad4O and Ad4l coincided roughly with a shift in
the proportions of the incidences of the three subtypes
(Ad4l/M1 to Ad4l/M3) within Ad4l, which we described
above. Before 1984, only Ad4l strains of subtype Ml were
found, whereas Ad4l/M2 strains accounted for about half of
the Ad4l strains isolated before 1983 and gradually declined
in number thereafter. The increase in the proportion of
Ad4l/M3 strains among the Ad4l strains paralleled the rise
in the proportion of Ad4l strains among AdF as a whole
(Fig. 5). Ad4l/M3 strains made up about 40% of the Ad4l
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FIG. 4. Annual distributions of Adl and Ad7 infections in the
period 1961 through 1989 and annual distributions of AdF and
rotavirus infections in the period 1981 through 1989. The meaning of
the designation "Ad4O + Ad4l" is the same as that described in the
legend to Fig. 1.
In the present report and in line with earlier studies (14,
15, 26, 27), we described the development of a panel of
MAbs that can be used for the rapid detection and typing of
Ad4O and Ad4l. Some of these MAbs were also used in
previous studies (32, 36, 40, 41) (Table 1). In view of the
close antigenic relationship between Ad4O and Ad4l in VN
assays and the marked antigenic variability within these two
types (9), there is a risk that anti-AdF MAbs would react
with certain strains of both types or, alternatively, that they
may not react with all the strains of the type concerned.
Unlike earlier studies (14, 15, 26, 27), our study reduced this
risk by assessing the specificities of the anti-AdF MAbs
against a panel of 35 genome types of Ad4O and Ad4l. The
relevance of this problem was illustrated by the finding of
Scott-Taylor et al. (24) that a commercial MAb-based
ELISA failed to demonstrate the presence of a highly
prevalent genome type in Canada. This variant is closely
related or identical to Ad41/D12, which is highly prevalent in
The Netherlands. As expected, seven fecal specimens from
the Canadian study proved to be positive in our typing
ELISA.
Evaluation of the specificities of the newly developed
MAbs showed that some of the MAbs indeed failed to react
with a proportion of the strains within the type involved
(Tables 1-4). Even when they did recognize all the genome
types within one type, they sometimes displayed different
levels of reactivity to these variants (MA41-1 in Tables 2 and
4). Three MAbs were selected for the detection and typing of
AdF strains. Type-specific MAb 40-1 and MAb 41-1 could be
used in a type-specific ELISA, and genus-specific MAb d-gl
could be used in a genus-specific ELISA. These ELISAs
were used to detect the presence of Ad4O or Ad4l, and of
adenoviruses in general, directly in stool samples.
The possibility of the existence of Ad4O or Ad4l strains
lacking the epitopes recognized by MAb 40-1 and MAb 41-1
or even novel types of AdF should be considered. Such
variants would, however, still be detected by the genus-
specific ELISA. Subsequent typing with polyclonal antisera
in VN tests would then identify any deviant variant of Ad4O
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or Ad4l. The reactivities of the genus-specific MAbs d-gl
and d-g2 were shown to be limited to the adenoviruses that
infect primates. They failed to detect adenoviruses from
nonprimate animals, including dogs, guinea pigs, and mice.
In contrast, MAb 2Hx-2 described by Cepko et al. (5)
reacted with adenoviruses from primates as well as with
canine, bovine, porcine, and murine adenoviruses.
The sensitivity of the typing ELISA proved to be greater
than that of EM and roughly the same as that of virus
isolation in Graham cells. However, the ELISA is more
rapid and less laborious than the two other techniques.
Moreover, several fecal samples scored positive by the
typing ELISA and EM but were negative by the virus
isolation procedure (data not shown).
On the basis of these results and by using the same MAbs,
an ELISA for the detection and typing of AdF was designed;
this ELISA will soon become commercially available (40).
The same MAbs were also applied successfully by others in
typing enteric adenoviruses for diagnostic purposes (36) and
in IEM analyses of fecal samples (41).
From a clinical point of view, a major advantage of
MAb-based ELISAs over tests with polyclonal antibodies
(12) is their ability to differentiate between enteric and
nonenteric adenoviruses. This is of diagnostic importance
because, in contrast to AdF, the presence of nonenteric
adenoviruses in infant stools is not associated with diarrhea
(2, 3). Although the polyclonal antibody-based tests gener-
ally do not detect nonenteric adenoviruses in stool speci-
mens because the levels of virus excretion are too low, a
certain proportion of such samples does score positive
(unpublished data), which may lead to erroneous conclu-
sions. Another diagnostic advantage of the MAb-based
ELISA system is the ability to discriminate between Ad4O
and Ad4l infections. Although the direct clinical implica-
tions of this differentiation seem limited (29), the present
study demonstrates its special relevance for epidemiological
investigations.
Our epidemiological studies showed that 4.0% of 6,666
fecal samples collected previously from diarrheic children in
The Netherlands scored positive in the typing ELISA. Of the
same collection of specimens, 21.8% scored positive for
rotavirus. Similar percentages have been found in other
countries: 4.1% (2), 7.9% (30), and 5.2% (20) for AdF and
45% (30) and 21% (20) for rotavirus. Rotavirus infections
peaked markedly in the winter months, whereas AdF ap-
peared to circulate more uniformly throughout the year (Fig.
2 and 3). These findings are in accordance with observations
by investigators in Britain and Sweden (23, 29) and show a
correspondence with the seasonal pattern of the endemic
Adl and Ad2 infections rather than with the epidemic Ad3
and Ad7 infections (Fig. 2). Furthermore, AdF infections
prevailed in the first half year of life and rotavirus infections
prevailed in the second half year of life (Fig. 1), which is in
agreement with the trends noted by investigators in the
United States and Britain (2, 23, 38).
A comparison of the numbers of isolations of Ad40 and
Ad4l made in The Netherlands by our laboratory over the
period 1981 through 1989 revealed a decrease in the rate of
isolation of Ad4O and a concomitant increase in the rate of
isolation of Ad4l (Fig. 1). The total annual number of AdF
isolates recovered, however, remained about the same (Fig.
2). If, on the basis of the close antigenic relationship in VN
tests, Ad4O and Ad4l are considered one antigenic cluster,
the incidence of infections with this cluster is subject to
relatively minor variations over the period involved. Al-
though data from only a limited period could be studied, this
observation also indicates that AdF should be classified
among the endemic group of adenoviruses (28, 37).
The MAbs developed in the present study distinguished
three subtypes of Ad4l, the antigenic differences of which
correlated with the presence or absence of two DNA restric-
tion sites within the hexon gene (Table 2), which is respon-
sible for type-specific reactivity (1, 32).
The three subtypes observed were not evenly distributed
over the observation period. Ad41/M3 took over from
Ad41/M1 and Ad4l/M2 to become the major subtype in The
Netherlands since 1983. In this connection it is interesting
that subtype Ad4l/M3 (genome type Ad4l/D4) was already
identified in Malaysia in 1979 (17). The proportional increase
in the circulation of subtype M3 within Ad41 coincided with
the overall rise in the incidence of Ad41 (Fig. 4). It is
possible that Ad41/M3 not only superseded Ad41/M1 and
Ad41/M2 but also superseded Ad4O. The cross-reactivity
between the two adenovirus types in VN tests (9) may have
resulted in a mutual competition in infecting susceptible
individuals.
A similar shift may have occurred in the United Kingdom.
Of 10 Ad41-positive fecal specimens collected in Manchester
in 1986 and 1987, 4 were shown to contain Ad41/M2 and 6
were shown to contain Ad41/M3 viruses by the MAb-based
ELISA. In contrast, 25 of 26 Ad41-positive fecal samples
collected in Manchester in 1988 proved to be Ad41/M3
(unpublished data). Recently, the disappearance of Ad4O
from the United Kingdom (Newcastle upon Tyne) (38),
Canada (Toronto) (4), and Japan (Tokyo) (25) in about 1985
was reported. Therefore, we speculate that a similar shift of
the Ad4l subtype has formed the basis for the epidemiolog-
ical phenomena in all the countries studied.
The serial succession of subtypes of Ad4l described here
reveals the change in certain antigenic sites during succes-
sive years, a phenomenon reminiscent of the events evolving
from interactions between the human immune system and
influenza viruses (35).
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